Lutein and zeaxanthin attenuates VEGF-induced neovascularisation in human retinal microvascular endothelial cells through a Nox4-dependent pathway
- 6 June 2020
- journal article
- research article
- Published by Elsevier BV in Experimental Eye Research
- Vol. 197, 108104
- https://doi.org/10.1016/j.exer.2020.108104
Abstract
No abstract availableKeywords
Funding Information
- Diabetes UK (15/0005284)
This publication has 59 references indexed in Scilit:
- Pathophysiology of Diabetic RetinopathyISRN Ophthalmology, 2013
- Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stressFree Radical Biology & Medicine, 2012
- Neurovascular Interaction and the Pathophysiology of Diabetic RetinopathyExperimental Diabetes Research, 2011
- Inhibition of Reactive Oxygen Species by Lovastatin Downregulates Vascular Endothelial Growth Factor Expression and Ameliorates Blood-Retinal Barrier Breakdown in db/db MiceDiabetes, 2010
- Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetesDiabetologia, 2010
- Association of diabetes with age-related macular degeneration in the EUREYE studyBritish Journal of Ophthalmology, 2009
- NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generationBiochemical Journal, 2007
- Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic RetinopathyOphthalmology, 2006
- Estrés oxidativo en un modelo de retinopatía diabética experimental II: utilidad de agentes secuestrantes de peroxinitritosArchivos de la Sociedad Española de Oftalmología, 2006
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004